Linden Advisors’s Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PIAI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-645,913
Closed -$353K 822
2021
Q4
$353K Hold
645,913
﹤0.01% 590
2021
Q3
$442K Hold
645,913
﹤0.01% 484
2021
Q2
$711K Hold
645,913
﹤0.01% 515
2021
Q1
$543K Sell
645,913
-20,753
-3% -$31.4K ﹤0.01% 563
2020
Q4
$1.06M Buy
+666,666
New +$804K 0.01% 376

Other funds holding PIAI.WS

Linden Advisors's PIAI.WS Position: Q1 2022 in Review

Linden Advisors sold out of Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PIAI.WS) in Q1 2022, closing a stake of 645,913 shares — an estimated $353K sold.

Linden Advisors first reported a position in PIAI.WS in Q4 2020 and held it in 5 quarters. The position peaked at $1.06M in Q4 2020. 29 funds tracked by Wall St. Rank hold PIAI.WS as of Q1 2022.

  • Linden Advisors reported no remaining Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Linden Advisors sold 645,913 Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $353K.
  • Linden Advisors first reported a position in Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2020 and held it in 5 quarters.
  • Linden Advisors's Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $1.06M in Q4 2020.
  • 29 funds tracked by Wall St. Rank held Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on Linden Advisors's 13F filing for Q1 2022, filed 16 May 2022.